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lass I phosphoinositide 3-kinases (PI3Ks) are implicated
in many cellular responses controlled by receptor
tyrosine kinases (RTKs), including actin cytoskeletal
remodeling. Within this pathway, Rac is a key downstream
target/effector of PI3K. However, how the signal is routed
from PI3K to Rac is unclear. One possible candidate for this
function is the Rac-activating complex Eps8–Abi1–Sos-1,
which possesses Rac-speciﬁc guanine nucleotide exchange
factor (GEF) activity. Here, we show that Abi1 (also known
as E3b1) recruits PI3K, via p85, into a multimolecular
signaling complex that includes Eps8 and Sos-1. The recruit-
ment of p85 to the Eps8–Abi1–Sos-1 complex and phos-
C
 
phatidylinositol 3, 4, 5 phosphate (PIP3), the catalytic
product of PI3K, concur to unmask its Rac-GEF activity in
vitro. Moreover, they are indispensable for the activation of
Rac and Rac-dependent actin remodeling in vivo. On growth
factor stimulation, endogenous p85 and Abi1 consistently
colocalize into membrane rufﬂes, and cells lacking p85 fail
to support Abi1-dependent Rac activation. Our results
deﬁne a mechanism whereby propagation of signals,
originating from RTKs or Ras and leading to actin reorgani-
zation, is controlled by direct physical interaction between
PI3K and a Rac-speciﬁc GEF complex.
 
Introduction
 
Class I phosphoinositide 3-kinases (PI3Ks)* mediate signals
emanating from receptor tyrosine kinases (RTKs), and are
composed of a catalytic (p110) and a regulatory (p85/p55)
subunit (Fruman et al., 1998; Vanhaesebroeck and Waterfield,
1999). Through its SH2 domains, p85 interacts with tyrosine-
phosphorylated RTKs, thus recruiting p110 to the plasma
membrane, where it can phosphorylate its substrates
(Cantrell, 2001). RasGTP also binds to p110 (Rodriguez-
Viciana et al., 1994). This is thought to concur to p110 full
catalytic activation (Rodriguez-Viciana et al., 1997; Walker
et al., 1999). The product of PI3K activity, phosphatidyl-
inositol 3, 4, 5 phosphate (PIP3), is required to regulate a
number of Rac-specific guanine nucleotide exchange factors
(GEFs), such as Vav, Tiam-1, Swap-70, and Sos-1 (Han et
al., 1998; Nimnual et al., 1998; Soisson et al., 1998; Fleming
et al., 2000; Shinohara et al., 2002), leading to activation of
Rac. These GEFs contain Dbl homology (DH)-pleckstrin
homology (PH) domains, which represent the catalytic core
and a phosphoinositide-binding surface, respectively. Bind-
ing of PIP3 to the PH domain is thought, in the case of Vav
and possibly of Sos-1, to relieve an intramolecular inhibitory
conformation, thereby allowing catalysis (Han et al., 1998;
Nimnual et al., 1998; Das et al., 2000); alternatively, as in
the case of Tiam1 and Swap-70, it promotes membrane re-
localization (Stam et al., 1997; Shinohara et al., 2002). In a
living cell, the situation is likely more complex, as supported
by findings that Rac-GEFs assemble into macromolecular
complexes that are essential for efficient catalysis and for
proper subcellular targeting. An exemplar case is provided by
the trimeric complex, Eps8–Abi1–Sos-1 (Scita et al., 1999).
This complex is indispensable for the activation of the Rac-
specific GEF activity of Sos-1 and for proper localization of
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the complex to dynamic actin structures (Scita et al., 2001;
Innocenti et al., 2002). In addition, disruption of the com-
plex by genetic removal of Eps8 or by dominant-negative
Abi1 abrogate Rac activation and Rac-dependent actin re-
modeling induced by RTKs, Ras, or PI3K (Scita et al.,
1999; Innocenti et al., 2002). The present studies were un-
dertaken to understand how the Eps8–Abi1–Sos-1 complex
is regulated by upstream signals.
 
Results and discussion
 
We searched for interaction(s) of the Eps8–Abi1–Sos-1 com-
plex with class I PI3K. Endogenous p85 and Abi1 could be
coimmunoprecipitated (Fig. 1 A, left, and supplemental materi-
als), and a wortmannin-sensitive (Fig S1, available at http://
www.jcb.org/cgi/content/full/jcb.200206079/DC1) PI3K en-
zymatic activity was detected in Abi1 immunocomplexes (Fig. 1
A, right), suggesting that the p110–p85 complex binds to Abi1.
GST-p85 or either of its SH2 domains could bind to Abi1
(Fig. 1 B) and to various pTyr-containing proteins, one of
which co-migrated with Abi1 (unpublished data). This, and
the observation that bacterially produced Abi1 (that is not
tyrosine phosphorylated) failed to interact with p85 (Fig. S1,
D), suggested that the interaction is mediated by pTyr in
Abi-1. Indeed, as previously reported, tyrosine phosphoryla-
tion of Abi1 was readily detectable (Juang and Hoffmann,
1999; Fan and Goff, 2000) and was abolished by treatment
with alkaline phosphatase (Fig. 1 C, left panels and supple-
mental materials). Finally, a Far-western analysis revealed
that the NH
 
2
 
-terminal SH2 of p85 bound directly and spe-
cifically to Abi1 in a phosphorylation-dependent manner
(Fig. 1 C). Notably, the recruitment of p85 to Abi1 was in-
dependent of RTK activation (unpublished data), in agree-
ment with the observation that Abi1 displays constitutive
levels of tyrosine phosphorylation (unpublished data).
Tyr
 
407
 
 of Abi1 was predicted by the NetPhos neural net-
work (Blom et al., 1999) as a strong candidate for phosphor-
ylation by tyrosine kinases (supplemental materials). Muta-
tion of Tyr
 
407
 
 to Phe abrogated the p85–Abi1 interaction
both in vitro (Fig. 1 D) and in vivo (Fig. 1 E). The overall
tyrosine phosphorylation of Abi1Y407F was not reduced, as
compared with wild-type Abi1 (unpublished data). Thus, al-
though other tyrosine residues are also phosphorylated in
Abi1, Tyr
 
407
 
 is absolutely critical for the interaction with
p85. Of note, Tyr
 
407
 
 is present in noncanonical context for
ligands of the SH2 domains of p85 (Songyang et al., 1993).
Thus, the possibility that in vivo, the interaction between
p85 and Abi1 is indirect, cannot be formally excluded, albeit
our Far-western data (Fig. 1 C) argue against it.
To assess whether p85 is associated to the Eps8–Abi1–Sos-1
complex (Fig. 2 A), we used Eps8
 
 
 
/
 
 
 
 fibroblasts in which
the expression of Eps8 was restored to physiological levels
(
 
 
 
/
 
 
 
 [Eps8myc] cells; Scita et al., 2001; Innocenti et al.,
2002). Endogenous Sos-1, Abi1, and p85 could be specifi-
cally detected in anti-myc immunoprecipitates (Fig. 2 A). In
addition, the disruption of the Eps8–Abi1 interaction with
the specific PPPPPVDYTEDEE peptide (but not with a con-
trol, PPPPPVAATEDEE, peptide; Mongiovi et al., 1999)
caused the disappearance of Abi1, p85, and Sos-1 from the
anti-myc immunoprecipitates (Fig. 2 A). Previously, we have
shown that Eps8, Abi1, and Sos-1 are enriched into mem-
brane ruffles induced by PDGF treatment (Scita et al., 2001).
Similarly, endogenous p85 was found to colocalize with Abi1
(Fig. 2 B) and Eps8 (unpublished data) on treatment with
PDGF. Thus, p85 is part of an Abi1-based signaling complex
that includes Eps8 and Sos-1 in vivo.
The immunoprecipitated Eps8–Abi1–Sos-1 complex dis-
plays Rac-specific GEF activity (Scita et al., 1999). This, and
Figure 1. p85 interacts with Abi1. (A) Left; lysates (5 mg) from 
MEFs were immunoprecipitated (IP) and immunoblotted (IB) with 
the indicated antibodies (ctr, preimmune serum). Abi1 could also 
be detected in p85 immunoprecipitates (supplemental materials). 
About 1% of total p85 could be found associated with Abi1 immuno-
precipitates. Right; lysates (5 mg; p85   0.3 mg) from MEFs were 
immunoprecipitated (IP) and immunoblotted (IB) with the indicated 
antibodies (top). The immunocomplexes were tested for PI3K lipid 
kinase activity by TLC (bottom; Domin et al., 1996). (B) Binding of 
GST-p85 fragments (amino acid boundaries or domains are indicated) 
to Abi1 from lysates of HA-Abi1–transfected 293T cells. The altered 
electrophoretic mobility of the Abi1 band in the 320–724 lane is 
due its co-migration with the GST-fusion protein. (C) Lysates (2 mg) 
from 293T cells transfected with HA-Abi1 were immunoprecipitated 
with anti-HA antibody. Immunoprecipitates, treated with alkaline 
phosphatase in the presence ( ) or absence ( ) of inhibitors (API), 
were immunoblotted (IB) with anti-HA (left) or anti-pY (middle), or 
analyzed in Far-western with the proteins indicated on the top. (D) 
Lysates (1 mg) from 293T cells, transfected with HA-tagged wild-type 
(WT) or Y407F Abi1, were subjected to in vitro binding with the 
GST-NH2-terminal SH2 domain of p85 (SH2-N) or GST alone. Similar 
results were also obtained using the COOH-terminal SH2 domain 
of p85, indicating that the apparent affinities of the SH2 domains 
of p85 for Abi1 were similar (not depicted). (E) Lysates (5 mg) from 
Cos-7 cells, transfected with HA-Abi1 (WT) or HA-Abi1Y407F, were 
immunoprecipitated (IP) and immunoblotted (IB) with the indicated 
antibodies (ctr, anti-flag antibody used as a control).T
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the results presented here, raise the possibility that the re-
cruitment in vivo of PI3K to the complex is also required.
Cells were transfected with a combination of Sos-1–
mycEps8–Abi1wt or Sos-1–mycEps8–Abi1Y407F, and Rac-
GEF assays were performed on anti-myc immunoprecipitates.
Trimeric Eps8–Abi1–Sos-1 complexes were readily detected
that contained similar amounts of the catalytic subunit Sos-1
(Fig. 3 A). Endogenous p85 (Fig. 3 A) and Rac-GEF activity
(Fig. 3 B) were present only in the complexes containing
Abi1wt, but not in those with Abi1Y407F.
Next, we performed Rac-GEF assays on Eps8–Abi1wt–
Sos-1 or Eps8–Abi1Y407F–Sos-1 immunocomplexes in the
presence of water-soluble phosphoinositides. The PH do-
 
main of Sos-1 displays selectivity for PI3,4,5P over the more
physiologically abundant PI4,5P (Rameh et al., 1997). Con-
sistently, the addition of PI3,4,5P (0.5 
 
 
 
M), the catalytic
product of PI3K, but not of PI4,5P, PI5P, or PI3P (unpub-
lished data and Fig. S3), led to a statistically significant in-
crease in the Rac-GEF activity of the Eps8–Abi1wt–Sos-1
complex (Fig. 3 B and supplemental materials). More
importantly, it restored the GEF activity of the Eps8–
Figure 2. p85 associates with the Eps8–Abi1–Sos-1 complex under 
physiological conditions. (A) Top; model of the Eps8–Abi1–p85–Sos-1 
complex. Bottom; lysates (10 mg) from  /  [Eps8myc] cells and 
supplemental materials) were immunoprecipitated (IP) with the 
indicated antibodies (ctr, irrelevant antibody) in the presence of 
the peptides PPPPPVDYTEDEE (competing) or PPPPPVAATEDEE 
(control). Immunoblotting (IB) was performed with the indicated 
antibodies. (B) Quiescent (Serum Starved) and PDGF-treated (PDGF) 
MEFs were fixed and stained with the indicated antibodies. Confocal 
analysis was carried and the apical sections are shown. Notably, 
colocalization between Abi1 and p85 could be detected only when 
the apical sections of PDGF-treated cells were analyzed. In these 
sections, the increase in the local concentration of the two proteins 
favors their detection by immunofluorescence, consistent with a 
notion that a relatively small (but physiologically relevant) pool of 
p85 is associated with Abi1 and enriched in ruffles. Arrows indicate 
dorsal ruffles. Bar, 10  m.
Figure 3. PI3K recruitment to the Eps8–Abi1–Sos-1 complex is 
required for Rac-GEF activity, which is further increased by PIP3. 
(A) Cos-7 cells were transfected (tfx) with mycEps8 and Sos-1, 
together with either Abi1wt (WT) or the Y407F mutant (Y407F). 
Lysates were immunoprecipitated (IP) and immunoblotted (IB) with 
the indicated antibodies. Control immunoprecipitates were obtained 
using an irrelevant antibody. (B) Rac-GEF activity was measured in 
aliquots of the immunoprecipitates shown in A, in the absence or 
presence of the indicated water-soluble phosphoinositides (Han et 
al., 1998; supplemental materials). The difference in the samples 
marked by the asterisks was significant (P   0.01) in a paired t test. 
(C) Cos-7 cells were transfected (tfx) with mycEps8 and Abi1, together 
with either Sos-1 (WT) or a dominant-negative mutant of Sos-1 
(DH ). Lysates were immunoprecipitated (IP) and immunoblotted 
(IB) with the indicated antibodies. (D) Rac-GEF activity was measured 
on aliquots of the immunoprecipitate containing equal amounts of 
wild-type Sos-1 and the Sos-1 DH  mutant shown in C, in the 
absence or presence of the indicated water-soluble phosphoinositides. 
The difference in the samples marked by the asterisks was significant 
(P   0.005) in a paired t test.T
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Abi1Y407F–Sos-1 complex (Fig. 3 B). The two events, p85
recruitment and PIP3 availability, might independently in-
fluence the Rac-GEF activity of the tricomplex, or might be
somehow integrated. Whatever the case, both the physical
presence of p85 and the availability of PIP3 seem to partici-
pate in the activation of the Rac-GEF activity of the Eps8–
Abi1–Sos-1 complex, at least in vitro.
To rule out the possibility that GEFs other than Sos-1
might be contained in the Eps8–Abi1–Sos-1 complex and
be responsible for the observed Rac-GEF activity, we engi-
neered a dominant-negative form of Sos-1, carrying point
mutations inactivating the DH domain (Soisson et al.,
1998; Mettouchi et al., 2001). Cells were transfected with a
combination of mycEps8, Abi1, and either wild-type Sos-1
or Sos-1DH
 
 
 
. Sos-1DH
 
 
 
 associates with the Eps8–Abi1
complex as efficiently as wild-type Sos-1 (Fig. 3 C). How-
ever, no Rac-GEF activity could be detected in Eps8–Abi1–
Sos-1DH
 
 
 
 immunocomplexes as compared with the Eps8–
Abi1–Sos-1 complex under conditions in which equal
amounts of wild-type or mutant Sos-1 were present (Fig. 3,
C and D). Moreover, the addition of water-soluble PIP3 in-
creased the Rac-GEF of the Eps8–Abi1–Sos-1, but not of
the Eps8–Abi–SosDH
 
 
 
 immunocomplex (Fig. 3 D). Thus,
Sos-1 is not only critical for Rac-GEF activity of the Eps8–
Abi1–p85–Sos-1 complex, but it is also required to confer
responsiveness to PIP3.
The above observations indicate that the recruitment of
PI3K by Abi1 into an Eps8–Abi1–Sos-1 complex is neces-
sary and sufficient to activate, in vitro, the Rac-GEF capabil-
ity of the latter. They further highlight a regulatory role ex-
erted by PIP3 on this complex. If these in vitro findings
were to translate into physiologically relevant events, then
one would predict that (1) interference with the formation
of the Eps8–Abi1–p85–Sos-1 complex either by preventing
the binding between Abi1 and p85 (Fig. 3 A) or by geneti-
cally removing p85; and (2) pharmacological inhibition of
PI3-K by wortmannin should affect Rac activation mediated
by the complex in vivo. As show in Fig. 4 A, both the basal
and the EGF-induced levels of Rac-GTP were increased by
the expression of wild-type Abi1, consistent with the notion
that Abi1 is rate-limiting in Rac activation (Innocenti et al.,
2002). However, no Rac activity could be detected when the
Abi1Y407F, or a mutant of Abi1 (Abi1DY), which does not
associate with Eps8, were used (Fig. 4 A). These results
strongly suggest that Abi1 mutants, defective in their ability
to assemble to PI3K or Eps8, are not only biologically inac-
tive, but act as dominant-negatives, most likely by sequester-
ing the other endogenous components in inactive com-
plexes. Moreover, a formal proof of the requirement of p85
for Abi1-dependent activation of Rac was obtained by using
fibroblasts in which both p85 isoforms (
 
 
 
 and 
 
 
 
) were ge-
netically removed (unpublished data). In these cells, expres-
sion of Abi1 failed to induce Rac activation, which was,
however, restored by reintroduction of p85
 
 
 
 (Fig. 4 B). Fi-
nally, treatment with wortmannin reduced (but did not ab-
rogate) EGF-dependent and EGF-independent Rac activa-
tion induced by Abi1 (Fig. 4 C). Similarly, the Rac-GEF
activity in the Eps8–Abi1–p85–Sos-1 immunocomplex was
only reduced by pretreatment of the cells with wortmannin
(unpublished data). Thus, all together, these data support
 
the notion that PI3K recruitment to the Eps8–Abi1–Sos-1
complex is physically required to elicit a basal Rac-GEF ac-
tivity, which is further increased by PIP3.
The trimeric complex Eps8–Abi1–Sos-1 is essential for
RTK-mediated actin cytoskeletal remodeling, as witnessed
by the lack of PDGF-induced Rac activation and Rac-
dependent membrane ruffling detected in Eps8
 
 
 
/
 
 
 
 cells
(Scita et al., 1999; Innocenti et al., 2002). To analyze the bi-
ological consequence of p85 recruitment by the tricomplex,
two approaches were undertaken. First, a phosphorylated
peptide encompassing Tyr
 
407
 
 of Abi, and corresponding to
the Abi1 binding site of p85, was used. This phosphorylated
peptide, but not its unphosphorylated version or one in
which the tyrosine residue was replaced by phenylalanine,
efficiently inhibited the binding of p85 to Abi1, but not to
activated PDGFR (Fig. S2). Microinjection of the phosphor-
ylated peptide (but not of the two control peptides) inhib-
ited PDGF-induced ruffles by more than 70% (Fig. 5 A).
Notably, inhibition of RTK-mediated ruffles could also be
Figure 4. p85 is required for Abi1-induced activation of Rac in 
vivo. Cos-7 cells, transfected (tfx) with HA-Rac together with HA-Abi1, 
HA-Abi1Y407F, HA-Abi1DY, or the empty vector (ctr) were treated 
with 100 ng/ml of EGF for 3 min ( ) or mock-treated ( ). Lysates 
were either incubated with GST-CRIB and detected with anti-Rac 
antibodies (RacGTP), or directly immunoblotted with the indicated 
antibody. (B) p85 /p85 -double (p85  / ) and p85 -single (p85 
 /  [p85 ]) knockout MEFs, transfected (tfx) with HA-Rac together 
with either an HA-Abi1 ( ) vector or the empty vector as control 
( ), were serum-starved for 24 h. Lysates were incubated with 
GST-CRIB as described above and detected with anti–HA-Rac 
antibody (RacGTP) or directly immunoblotted with the indicated 
antibody. (C) Cos-7 cells, transfected (tfx) with HA-Rac together 
with Abi1 (Abi WT) or the empty vector (ctr), were incubated for 1 h 
with 100 nM of wortmannin (Wort,   lanes) or vehicle (Wort,   lanes), 
as a control, and treated with EGF (EGF,   lanes) or mock-treated 
(EGF,   lanes). Rac-GTP levels, total Rac, and the expression of 
Abi1 were determined as in A.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
Rac activation by PI3K |
 
 Innocenti et al. 21
 
caused by microinjection of anti-Abi1 antibodies (Scita et
al., 1999 and Fig. S4), which, however, did not affect TPA-
induced actin remodeling, indicating that additional path-
ways leading to Rac activation (and possibly reflecting the si-
multaneous presence of several Rac GEFs in the cells) are
at play (supplemental information, Fig. 4). Second, we
cotransfected the activated version of either Ras (RasV12) or
Rac (RacQL) together with either Abi1wt or the Abi1Y407F
mutant, and scored the formation of ruffles. RasV12-
induced (but not RacQL-induced) ruffles were efficiently
inhibited by coexpression of Abi1Y407F, but not by Abi1wt
(Fig. 5 B). Thus, the recruitment of PI3K by Abi1 plays a
critical role in RTK-induced actin remodeling and is essen-
tial for the propagation of signals from Ras to Rac.
Our results elucidate the molecular mechanisms through
which PI3K is coupled to Rac via the Eps8–Abi1–Sos-1 tri-
complex. In vitro Rac-GEF assays revealed that the physical
interaction with p85 and the availability of PIP3 concur to
stimulate the Rac-GEF activity of the tricomplex. This likely
reflects the situation in vivo as supported by two observa-
tions. First, interference with the association between p85
and the tricomplex results in lack of Rac activation and actin
cytoskeleton remodeling. Second, there is an absolute re-
quirement for PIP3 in Rac activation, as shown by several
studies using enzymatic inhibitors of PI3K (Cantrell, 2001).
The most simple explanation for the sum of our results is
that recruitment of p85 to the Eps8–Abi1–Sos-1 tricomplex
unmasks a basal Rac-GEF activity. This is further supported
by the finding (Fig. 4) that the overexpression of Abi1 leads
to increased Rac-GTP levels, in a p85-dependent manner,
even in the absence of growth factor stimulation. However,
this basal Rac-GEF activity requires further stimulation by
PIP3s, which in vivo, are produced after RTK activation, to
achieve a threshold of biological significance. Thus, in vivo,
the integrity of the complex and PI3K activity are both nec-
essary for RTK-dependent activation of Rac. However, it is
clear that further work will be needed to define the exact in-
terplay between the effects of the physical recruitment of
PI3K and of its catalytic activity on the Rac-GEF activity of
the Eps8–Abi1–Sos-1 tricomplex. Finally, the RTK-depen-
dent relocalization of the macromolecular complex at sites
where membrane ruffling takes place (Fig. 2 B; for review
see Scita et al., 2001) suggests that the recruitment of the
complex to proper sites within the cell’s formation is key for
signal propagation, further ensuring that the production of
PIP3 is directed to and modulates the activation of Rac-
GEFs, and thereby of Rac, in a defined microenvironment.
 
Materials and methods
 
Expression vectors, antibodies, and cells
 
Cytomegalovirus-, adenovirus-, and elongation factor-1
 
 
 
–promoter-based
eukaryotic expression vectors and GST-fusion bacterial expression vectors
were generated by recombinant PCR. The mutants of Abi1 (Abi1-Y407F
and Abi1-Y283F), in which F replaced the Y residues, and the Sos-1 DH, in
Figure 5. The Abi1-p85 association is required 
for ruffling by activated RTK and Ras, but not by 
activated Rac. (A) Quiescent MEFs, microinjected 
with the indicated peptides together with rabbit 
IgG (supplemental materials), were treated with 
PDGF for 10 min. Cells were fixed and stained 
with rhodamine-conjugated phalloidin to detect 
F-actin (red) and anti–rabbit IgG (not depicted) to 
detect microinjected cells (indicated by asterisks). 
More than 100 cells were injected in each exper-
iment. In the bar graph, a quantitation of the 
experiment is reported. (B) MEFs were transfected, 
as indicated on the top, with expression vectors 
for either RasV12 or RacQL, together with either 
ECFP-Abi1WT or ECFP-Abi1Y407F. After serum 
starvation, cells were fixed and stained with 
rhodamine-conjugated phalloidin (ph, red). 
Expression of the transfected proteins was detected 
(green) with either anti-Ras or anti-Rac antibodies 
or by epifluorescence (ECFP). The percentage of 
transfected cells undergoing ruffling is reported 
in Materials and methods. Bars, 10  m.T
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which the residues E357 and L358 were replaced by A, were generated by
PCR-based site-directed mutagenesis and cloned in the expression vectors
pCEFL-HA or pECFP-C1. All constructs were sequence-verified.
Antibodies were as follows: anti-Eps8 (Fazioli et al., 1993), anti-Abi1
(Biesova et al., 1997) and anti-EGFR sera (Di Fiore et al., 1990); rabbit
polyclonals anti–Sos-1; anti-PDGFR 
 
 
 
 and 
 
 
 
 (Santa Cruz Biotechnology,
Inc.); monoclonal anti–phosphotyrosine, polyclonal and monoclonal anti-
p85 (UBI) anti–v-H-Ras (Oncogene Research Products), anti-HA11 and
anti-myc 9E10, (BAbCo); anti-Rac (Transduction Laboratories).
Mouse embryonic fibroblasts (MEFs) were derived from embryos of
p85
 
  
 
/
 
 
 
, p85
 
  
 
/
 
 
 
, and wild-type mice (129XC57BL/6). The generation
of p85
 
  
 
/
 
 
 
 mice and the establishment of the embryonic fibroblasts from
crosses with p85
 
  
 
/
 
  
 
mice were performed as follows: the embryos were
transferred onto gelatinized tissue culture dishes and the MEFs were im-
mortalized after few passages using SV-40 large T antigen expressed as ret-
roviral vector. The genotypes of the cells were determined by PCR. Nota-
bly, growth factor–mediated activation of Rac, but not of ERK, is
completely abrogated in p85 double knockout cells, further supporting the
specific and critical role of p85 in this pathway.
 
Biochemical assays
 
Standard procedure of protein analysis (in vitro binding, cell lysis, coim-
munoprecipitation, and Far-western) was as described previously (Fazioli
et al., 1993). The lanes labeled “lysate” were loaded with 100 
 
 
 
g of the
appropriate lysate.
The levels of Rac-GTP were measured by affinity precipitation using
GST-CRIB (Cdc42 and Rac interactive region) of PAK65 (Manser et al.,
1994), as described previously (Scita et al., 1999). Abi1 was coexpressed
with wild-type HA-tag Rac at a ratio of 10/1 of Abi1/Rac. Under these con-
ditions, all cells expressing HA-tag Rac were also positive for Abi1. Addi-
tionally, the levels of Rac-GTP induced by expression of Abi1 were similar
to those obtained by coexpressing HA-Rac with Tiam1, a known GEF
for Rac.
In vitro GEF activity toward Rac was performed as described previously
(Scita et al., 1999). For the Rac-GEF in Fig. 3 B, performed in the presence
of the water-soluble phospholipids, it is noteworthy that PIP3, which re-
stored the Rac-GEF activity of the Eps8–Abi1Y407F–Sos-1 complex (Fig. 3
B), was shown to bind to and permit the association to Rac of the bacteri-
ally produced and purified DH-PH domain of Sos-1 (Das et al., 2000).
None of the water-soluble phospholipids used had any effect on the re-
lease of guanine nucleotides from [
 
3
 
H]-loaded Rac incubated in the pres-
ence of buffer alone or of mock immunoprecipitates. Data are the mean 
 
 
 
SEM of at least three independent experiments performed in triplicate. Re-
sults are expressed as the [
 
3
 
H]GDP released after 20 min relative to time 0,
after subtracting the background counts released in control reactions (ob-
tained in the presence of immunoprecipitates performed with an ANTI-
FLAG
 
®
 
 antibody as a control).
 
Microinjection of peptides and immunofluorescence
 
Peptides were purified by high pressure liquid chromatography (purity
grade 
 
 
 
95%) and lyophilized (Eurogentec). The peptides solubilized at a
concentration of 15 mg/ml in PBS in the presence of 12 mg/ml rabbit IgG
were microinjected into quiescent fibroblasts. After 1 h, cells were treated
with 10 ng/ml PDGF before fixation and staining.
For the experiments shown in Fig. 5 B, fibroblasts seeded on gelatin
were transfected with various combinations of RasV12, RacQL, Abi1WT,
and Abi1Y407F as indicated. After serum starvation, cells were fixed and
stained with the appropriate antibodies to detect activated Ras or Rac.
F-actin was revealed by rhodamine-conjugated phalloidin (red). Detection
of ECFP-Abi1WT or ECFP-Abi1Y407F was by epifluorescence (ECFP). In
the cotransfection experiments, a molar ratio of 1:3 of the activated GTP-
ases to the ECFP-Abi1 constructs was used so that all the epifluorescent
cells also expressed the corresponding GTPase. The percentage of trans-
fected cells (mean 
 
 
 
 SEM) undergoing ruffling was as follows: RasV12
 
  
 
65 
 
 
 
 3%; RasV12
 
  
 
 Abi1WT
 
  
 
 62 
 
 
 
 4%; RasV12 
 
  
 
Abi1Y407F 
 
 
 
 16 
 
 
 
2%; RacQL 
 
 
 
 93 
 
 
 
 3%; RacQL 
 
 
 
 Abi1WT 
 
 
 
 90 
 
 
 
 4%; RacQL 
 
 
 
Abi1Y407F 
 
 
 
 95 
 
 
 
 5%.
 
Mapping of Abi1 tyrosine responsible for the binding to p85
 
To map the tyrosine residues of Abi1 responsible for the interaction with
p85, we performed a candidate approach. Mutation to phenylalanine of
the sole tyrosine (Y283) of Abi1 embedded in a stretch of amino acids
compatible with a consensus sequence for ligands of the SH2 domain of
p85 (Songyang et al., 1993) did not prevent interaction (Fig. 1 E of the sup-
plemental materials). Mutation of tyrosine 407 to phenylalanine abrogated
the binding of Abi1 to both the NH
 
2
 
-terminal SH2 domain of p85 in in
 
vitro binding experiments (Fig. 1 D) and to native p85 in coimmunoprecip-
itation (Fig. 1 E). Site-directed mutagenesis was carried out using PCR-
based techniques.
 
Online supplemental material
 
Fig. S1 shows that (1) the lipid kinase activity associated to Abi1 immuno-
precipitates is wortmannin-sensitive; (2) Abi1 and p85 coimmunoprecipi-
tate on overexpression; (3) no interaction could be detected between p85
and bacterially produced, GST-fused Abi1 fragments; (4) Abi1 is phosphor-
ylated on tyrosine in mammalian cells; and (5) phosphotyrosine 407 (but
not 283) of Abi1 mediated the association with the SH2 domain of p85.
Fig. S2 shows that the Abi1 peptide encompassing the p85 interaction site
phosphorylated on tyrosine 407, but not the one in which Y407 was re-
placed by F, efficiently competed the p85–Abi1 interaction. Fig. S3 shows
the dose-dependent effects exerted by water-soluble PIPs on the Rac-
specific GEF activity of the Eps8–Abi1–p85–Sos-1 complex, extending
the observations reported in Fig. 3. Fig. S4 shows that microinjection of
anti-Abi1 IgG abrogates PDGF-, but not TPA-induced ruffling. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200206079/DC1.
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